Rhuzdah
- Product NDC
- 59651-740
- Requested package NDC
- 59651-740-92
- 11-digit product format
- 596510740
- Labeler code
- 59651
- Product ID
- 59651-740_450fc33f-0716-47fe-b810-f10f372ab98a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- norethindrone and ethinyl estradiol tablet
- Dosage form
- KIT
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA207585
- Marketing category
- ANDA
- Marketing start
- 2022-10-11
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207585-001 | RHUZDAH | ETHINYL ESTRADIOL; NORETHINDRONE | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | AB | 2022-10-11 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | AB | 2022-10-11 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | AB | 2022-10-11 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | AB | 2022-10-11 | f41ea6bd6efb… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A207585-001 | RHUZDAH | 0.035MG;0.4MG | TABLET / ORAL-28 | 2022-10-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-05-13 08:27 UTC | 2023-05 | A207585-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A207585-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207585-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207585-001 | AB | 1 | f41ea6bd6efb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rhuzdah
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| dea10e78-0e7b-4404-9c3a-ed2447a1788b | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59651-740-88 | Rhuzdah | 1 in 1 POUCH | KIT | 1 | 3 | |
| 59651-740-88 | Rhuzdah | 3 in 1 CARTON | KIT | 3 | 3 | |
| 59651-740-92 | Rhuzdah | 6 in 1 CARTON | KIT | 6 | 3 | |
| 59651-740-92 | Rhuzdah | 1 in 1 POUCH | KIT | 1 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rhuzdah | NORETHINDRONE AND ETHINYL ESTRADIOL TABLET | Aurobindo Pharma Limited | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 2023-11-23 | Warnings, Adverse reactions | 207585 ANDA207585 59651-740-92 59651-740 59651074092 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2624207 | {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Rhuzdah 28 Day] | BPCK | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 749736 | {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack | GPCK | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 749736 | Eth estra-Noreth 0.035-0.4 MG (21) Oral Tablet / Inert 1 MG (7) Oral Tablet 28 Day Pack | PSN | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 748797 | inert 1 MG Oral Tablet | PSN | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 238015 | norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 2624207 | Rhuzdah 28 Day Pack | PSN | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 238015 | ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet | SCD | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 748797 | inert ingredients 1 MG Oral Tablet | SCD | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
| 2624207 | Rhuzdah 28 Day Pack | SY | dea10e78-0e7b-4404-9c3a-ed2447a1788b | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 59651-740-92 | 59651074092 | 6 POUCH in 1 CARTON (59651-740-92) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK | 6 pouch | 2022-10-11 | 0000-00-00 | No | No | Current |